Fibrotic response after Baerveldt glaucoma drainage device surgery: an initial sight-threatening sign in eyes with refractory childhood glaucoma
Japanese Journal of Ophthalmology · 2026-07 · 70 (4) · 923-930
DOI: 10.1007/s10384-026-01357-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Ophthalmology, online erschienen am 02.05.2026. Verfasst von Rumi Kawashima und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Graduate School of Medicine, The University of Osaka, Yamadaoka 2-2, Suita, Osaka, 565-0871, Japan. Hauptthemen laut MEDLINE: Glaucoma Drainage Implants, Intraocular Pressure, Glaucoma, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Japan Agency for Medical Research and Development, The University of Osaka.
Abstract (Originalsprache)
Purpose
We report the pathological analysis of a postoperative fibrotic reaction as an initial sign of a sight-threatening complication observed during the 2-year outcomes follow up of Baerveldt glaucoma implant (BGI) surgery in eyes with refractory childhood glaucoma. Study design Retrospective case series.
Methods
Fifteen eyes of 10 patients with refractory childhood glaucoma underwent BGI surgery between 2013 and 2020 at the University of Osaka Hospital. Patients were followed for a minimum of 2 years postoperatively. We investigated the postoperative complications, and histopathologically analyzed the specimens obtained from three eyes with postoperative fibrous membranes on the irises.
Results
Nine eyes (60%) had a postoperative fibrous membrane around the tube or on the iris close to the tube, whereas two eyes developed a tractional retinal detachment. The pathological results indicated the tissues were eosinophilic fibrous scar tissues that did not have inflammatory or neoplastic lesions.
Conclusion
BGI surgery was effective in patients with refractory childhood glaucoma. However, clinicians should be alert to the potential for development of fibrotic ocular inflammation in refractory childhood glaucoma eyes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Graduate School of Medicine, The University of Osaka, Yamadaoka 2-2, Suita, Osaka, 565-0871, Japan.
- Department of Ophthalmology, Graduate School of Medicine, The University of Osaka, Yamadaoka 2-2, Suita, Osaka, 565-0871, Japan. kenmatsu@ophthal.med.osaka-u.ac.jp.
- Department of Pathology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
- Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka, Osaka, Japan.
Förderung
- JSPS KAKENHI
- Japan Agency for Medical Research and Development
- The University of Osaka
Zitieren
APA
Kawashima, R., Matsushita, K., Kurashige, M., Matsui, T., Motoyama, Y., Fujino, T., Morii, E., & Nishida, K. (2026). Fibrotic response after Baerveldt glaucoma drainage device surgery: an initial sight-threatening sign in eyes with refractory childhood glaucoma. Japanese Journal of Ophthalmology, 70(4), 923-930. https://doi.org/10.1007/s10384-026-01357-w
Vancouver
Kawashima R, Matsushita K, Kurashige M, Matsui T, Motoyama Y, Fujino T, et al. Fibrotic response after Baerveldt glaucoma drainage device surgery: an initial sight-threatening sign in eyes with refractory childhood glaucoma. Japanese Journal of Ophthalmology. 2026;70(4):923-930. doi:10.1007/s10384-026-01357-w
BibTeX
@article{Kawashima2026,
author = {Kawashima, Rumi and Matsushita, Kenji and Kurashige, Masako and Matsui, Takahiro and Motoyama, Yuichi and Fujino, Takahiro and Morii, Eiichi and Nishida, Kohji},
title = {Fibrotic response after Baerveldt glaucoma drainage device surgery: an initial sight-threatening sign in eyes with refractory childhood glaucoma},
journal = {Japanese Journal of Ophthalmology},
year = {2026},
volume = {70},
number = {4},
pages = {923--930},
doi = {10.1007/s10384-026-01357-w}
}
EUVIMED